Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Differential expression of apoptomiRs in myeloproliferative neoplasms.

Nunes NS, Tognon R, Moura LG, Kashima S, Covas DT, Santana M, Souto EX, Zanichelli MA, Simões BP, Souza AM, Castro FA.

Leuk Lymphoma. 2013 Sep;54(9):2047-51. doi: 10.3109/10428194.2013.767453. Epub 2013 Mar 8. No abstract available.

PMID:
23394459
[PubMed - indexed for MEDLINE]
2.

MicroRNAs in myeloproliferative neoplasms.

Zhan H, Cardozo C, Raza A.

Br J Haematol. 2013 May;161(4):471-83. doi: 10.1111/bjh.12276. Epub 2013 Feb 25. Review.

PMID:
23432162
[PubMed - indexed for MEDLINE]
3.

MicroRNAs in myeloid malignancies.

Gordon JE, Wong JJ, Rasko JE.

Br J Haematol. 2013 Jul;162(2):162-76. doi: 10.1111/bjh.12364. Epub 2013 May 16. Review.

PMID:
23679825
[PubMed - indexed for MEDLINE]
4.

[Advance of studies on role of miRNA in hematopoietic regulation and myeloproliferative neoplasms].

Lin J, Zhan R.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Aug;19(4):1071-4. Review. Chinese.

PMID:
21867646
[PubMed - indexed for MEDLINE]
5.

Oncogenic kinases of myeloproliferative disorders induce both protein synthesis and G1 activators.

Lelièvre H, Cervera N, Finetti P, Delhommeau F, Vainchenker W, Bertucci F, Birnbaum D.

Leukemia. 2006 Oct;20(10):1885-8. Epub 2006 Aug 10. No abstract available.

PMID:
16900207
[PubMed - indexed for MEDLINE]
6.

Response.

Xu Y, Zheng M, Khuong A, Merritt RE, Shrager JB, Wakelee HA, Kratzke RA, Hoang CD.

Chest. 2013 Dec;144(6):1971-2. doi: 10.1378/chest.13-1931. No abstract available.

PMID:
24297135
[PubMed - indexed for MEDLINE]
7.

Differential expression of apoptosis-related genes from death receptor pathway in chronic myeloproliferative diseases.

Tognon R, Gasparotto EP, Leroy JM, Oliveira GL, Neves RP, Carrara Rde C, Kashima S, Covas DT, Santana M, Souto EX, Zanichelli MA, Velano CE, Simões BP, Alberto FL, Miyashiro K, de Souza AM, Amarante-Mendes GP, de Castro FA.

J Clin Pathol. 2011 Jan;64(1):75-82. doi: 10.1136/jcp.2010.080895. Epub 2010 Nov 2.

PMID:
21045235
[PubMed - indexed for MEDLINE]
8.

Myelodysplastic/myeloproliferative disorders.

Malcovati L, Cazzola M.

Haematologica. 2008 Jan;93(1):4-6. doi: 10.3324/haematol.11374. No abstract available.

PMID:
18166777
[PubMed - indexed for MEDLINE]
Free Article
9.

The role of HMGA2 in the proliferation and expansion of a hematopoietic cell in myeloproliferative neoplasms.

Ikeda K, Ogawa K, Takeishi Y.

Fukushima J Med Sci. 2012;58(2):91-100. Review.

PMID:
23237864
[PubMed - indexed for MEDLINE]
Free Article
10.

Characterization and discovery of novel miRNAs and moRNAs in JAK2V617F-mutated SET2 cells.

Bortoluzzi S, Bisognin A, Biasiolo M, Guglielmelli P, Biamonte F, Norfo R, Manfredini R, Vannucchi AM; AGIMM (Associazione Italiana per la Ricerca sul Cancro–Gruppo Italiano Malattie Mieloproliferative) Investigators.

Blood. 2012 Mar 29;119(13):e120-30. doi: 10.1182/blood-2011-07-368001. Epub 2012 Jan 5.

PMID:
22223824
[PubMed - indexed for MEDLINE]
Free Article
11.

JAK2 and genomic instability in the myeloproliferative neoplasms: a case of the chicken or the egg?

Scott LM, Rebel VI.

Am J Hematol. 2012 Nov;87(11):1028-36. doi: 10.1002/ajh.23243. Epub 2012 May 28. Review.

PMID:
22641564
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

The roles of microRNA in cancer and apoptosis.

Lynam-Lennon N, Maher SG, Reynolds JV.

Biol Rev Camb Philos Soc. 2009 Feb;84(1):55-71. doi: 10.1111/j.1469-185X.2008.00061.x. Epub 2008 Nov 22. Review.

PMID:
19046400
[PubMed - indexed for MEDLINE]
13.

MicroRNAs as cancer players: potential clinical and biological effects.

Bandres E, Agirre X, Ramirez N, Zarate R, Garcia-Foncillas J.

DNA Cell Biol. 2007 May;26(5):273-82. Review.

PMID:
17504023
[PubMed - indexed for MEDLINE]
14.

Jak2: normal function and role in hematopoietic disorders.

Ihle JN, Gilliland DG.

Curr Opin Genet Dev. 2007 Feb;17(1):8-14. Epub 2007 Jan 8. Review.

PMID:
17208428
[PubMed - indexed for MEDLINE]
15.

MicroRNA expression signatures in solid malignancies.

Galasso M, Sandhu SK, Volinia S.

Cancer J. 2012 May-Jun;18(3):238-43. doi: 10.1097/PPO.0b013e318258b5f4. Review.

PMID:
22647360
[PubMed - indexed for MEDLINE]
16.

JAK2 V617F mutation, PRV-1 overexpression and endogenous erythroid colony formation show different coexpression patterns among Ph-negative chronic myeloproliferative disorders.

Bellosillo B, Besses C, Florensa L, Solé F, Serrano S.

Leukemia. 2006 Apr;20(4):736-7. No abstract available.

PMID:
16453004
[PubMed - indexed for MEDLINE]
17.

Apoptomirs: small molecules have gained the license to kill.

Vecchione A, Croce CM.

Endocr Relat Cancer. 2010 Jan 29;17(1):F37-50. doi: 10.1677/ERC-09-0163. Print 2010 Mar. Review.

PMID:
19815577
[PubMed - indexed for MEDLINE]
Free Article
18.

Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease.

Chan IT, Kutok JL, Williams IR, Cohen S, Kelly L, Shigematsu H, Johnson L, Akashi K, Tuveson DA, Jacks T, Gilliland DG.

J Clin Invest. 2004 Feb;113(4):528-38.

PMID:
14966562
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms.

Chim CS, Wan TS, Wong KY, Fung TK, Drexler HG, Wong KF.

J Transl Med. 2011 Nov 14;9:197. doi: 10.1186/1479-5876-9-197.

PMID:
22082000
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

miR-433 is aberrantly expressed in myeloproliferative neoplasms and suppresses hematopoietic cell growth and differentiation.

Lin X, Rice KL, Buzzai M, Hexner E, Costa FF, Kilpivaara O, Mullally A, Soares MB, Ebert BL, Levine R, Licht JD.

Leukemia. 2013 Feb;27(2):344-52. doi: 10.1038/leu.2012.224. Epub 2012 Aug 6.

PMID:
22864358
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk